CLASS II ONGOING Drug recall · Reported 17 Jun 2026 · FDA Enforcement Report

Gsms Incorporated, Niacin Extended-release Tablets, USP, 1,000 MG recalled

Golden State Medical Supply is recalling Gsms Incorporated, Niacin Extended-release Tablets, USP, 1,000 MG. The recall was initiated on 29 May 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027.
NDC51407-267, 51407-268
Quantity recalled2,961 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0587-2026
FDA event ID
99127
Recalling firm
Golden State Medical Supply, Camarillo, CA
Brand
Niacin
Manufacturer
Golden State Medical Supply, Inc.
Classification
Class II
Status
Ongoing
Recall initiated
29 May 2026
FDA classified
11 Jun 2026
Reported
17 Jun 2026
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

29 May 2026Recall initiated by company
11 Jun 2026Classified by FDA+13 days
17 Jun 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90.

Where it was distributed

Within the U.S Market.

Questions about this recall

Why was it recalled?

Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.

Which lots are affected?

Lots: GS065128, GS065844, GS066695, GS067432, GS067993, expires: 01/31/2027.

Where was it sold?

Within the U.S Market.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Golden State Medical Supply

All 55

Other Niacin recalls

All 10